Bleomycin Injection IP 15 Units | Bleocel 15 Cancer Treatment | No Style Like

EGP1400
NameBleomycin Injection IP 15 Units (Bleocel 15)
BrandCelon Labs
Strength15 Units
Quantity / Size1 Vial
FormLyophilized Powder for Injection
AppearanceBox + Glass Vial with Red Cap
Expiry DateDepends on Batch (e.g., 04/2023)
Country of OriginIndia
Product CodeBMI2114AC

Bleomycin Injection IP 15 Units (Bleocel 15) is an anti-cancer medicine used to treat testicular cancer, skin cancer, lymphoma, and lung cancer. Order now from No Style Like.

Erleada™ 60 mg Apalutamide Tablets for Prostate Cancer | Janssen | No Style Like

Original price was: EGP74164.Current price is: EGP59000.
NameErleada™ 60 mg
BrandJanssen – Johnson & Johnson
Strength60 mg
Quantity / Pack size120 film-coated tablets
FormFilm-coated tablets
AppearanceCarton box containing a plastic bottle with 120 tablets inside
Expiry dateAs indicated on the pack (usually 3 years from production date)
Country of originEuropean Union – Janssen
Product codeEDA Reg. No. 32480/2013

Erleada™ 60 mg film-coated tablets contain the active ingredient Apalutamide. It is indicated for the treatment of advanced and non-metastatic prostate cancer, developed by Janssen with proven clinical efficacy.

Kisqali 200 mg (Ribociclib) – Targeted Breast Cancer Treatment

Original price was: EGP69366.Current price is: EGP55000.
NameKisqali 200 mg
BrandNovartis
Strength200 mg
Quantity / Size63 film-coated tablets
FormOral tablets
AppearanceCarton box with blister packs
Expiry DatePrinted on the package
Country of OriginSwitzerland / Germany
Product Code[Insert official barcode/serial code]

Kisqali 200 mg (Ribociclib) by Novartis is prescribed for HR+/HER2- advanced or metastatic breast cancer. It slows cancer cell growth and is used with hormonal therapy.